Publicaciones
-
Arroyo-Ródenas, J, Falgas, A, Díez-Alonso, L, Martinez-Moreno, A, Roca-Ho, H, Gil-Etayo, FJ, Pérez-Pons, A, Aguilar-Sopeña, O, Velasco-Sidro, M, Gómez-Rosel, M, Jiménez-Matías, B, Muñoz-Sánchez, G, Pacheco, Y, Bravo-Martín, C, Ramírez-Fernández, A, Jiménez-Reinoso, A, González-Navarro, EA, Juan-Otero M, Orfao, A, Blanco, B, Roda-Navarro, P, Bueno, C, Menéndez, P and Alvarez-Vallina, L.
CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression.
Journal for ImmunoTherapy of Cancer . 13(4): . Nº de citas: 6
-
Krawczyk M, Fernandez-Fuentes N, Fidyt K, Winiarski T, Pepek M, Graczyk-Jarzynka A, Davis J, Bousquets-Muñoz P, Puente XS, Menendez P, Benard E, Wälchli S, Thomas-Tikhonenko A and Winiarska M.
The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.
bioRxiv : the preprint server for biology . : .
-
Petazzi, P, Ventura, T, Luongo, FP, McClafferty, H, May, A, Taylor, HA, Shipston, MJ, Romanò, N, Forrester, LM, Menendez, P and Fidanza, A.
A novel human pluripotent stem cell gene activation system identifies IGFBP2 as a mediator in the production of haematopoietic progenitors in vitro.
eLife . 13: . Nº de citas: 1
-
Fernández N, Petazzi P, Mulens-Arias V, Pérez LG, Menéndez P and Díaz VM.
A roadmap for systematic humanization of a chimeric antigen receptor: preclinical validation of a humanized CD22 scFv as a model.
EXPERIMENTAL HEMATOLOGY . : 105424-105424.
